The Journal of Immunology, Vol 140, Issue 8 2565-2568, Copyright © 1988 by American Association of Immunologists

ARTICLES

Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin [published erratum appears in J Immunol 1988 Jul 15;141(2):709]

MC Sirianni, S Soddu, W Malorni, G Arancia, F Aiuti and S] Soddus S$[corrected to Soddu
Department of Clinical Immunology, University of Rome, Italy.

Previous studies have demonstrated the importance of some cytoskeleton components in killing mechanisms. In fact, a microtubule and microfilament (MF) rearrangement in the lytic sequence of CTL and NK cells has been observed. In particular, MF seem to be related to the binding phase, because MF inhibitors suppress the binding of NK cells to the target, whereas microtubule inhibitors suppress only the killing phase. In this paper, the distribution of two cytoskeleton components, actin and alpha- and beta-tubulin, has been studied in PBL from AIDS patients, who maintain the capacity to bind to the target cell line K562 but are not able to kill it. PBL were labeled with mAb to these two cytoskeleton components, and then indirect immunofluorescence was used to visualize their distribution in the conjugates. A normal polarization of actin in the effector PBL was found, whereas no tubulin rearrangement was evident in the effector and target cells. On the contrary, in conjugates of PBL or large granular lymphocytes from normal donors and K562, a polarization of actin in the effector cell and a polarization of tubulin both in the effector and in the target cells, at the site of the attachment, was evident. These data suggest that a deficiency of tubulin rearrangement may underlie the inability of the NK cells from AIDS patients to kill their target.

This article has been cited by other articles:

				A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination J. Leukoc. Biol., July 1, 2008; 84(1): 27 - 49. [Abstract] [Full Text] [PDF]

				W. Malorni, M. G. Quaranta, E. Straface, L. Falzano, A. Fabbri, M. Viora, and C. Fiorentini The Rac-Activating Toxin Cytotoxic Necrotizing Factor 1 Oversees NK Cell-Mediated Activity by Regulating the Actin/Microtubule Interplay J. Immunol., October 15, 2003; 171(8): 4195 - 4202. [Abstract] [Full Text] [PDF]

				S. Fais and W. Malorni Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions J. Leukoc. Biol., May 1, 2003; 73(5): 556 - 563. [Abstract] [Full Text] [PDF]

				R. Tarazona, G. Lopez-Lluch, M.-D. Galiani, E. Aguado, F. Barahona, R. Solana, and J. Pena HLA-B2702 (77-83/83-77) Peptide Binds to {beta}-Tubulin on Human NK Cells and Blocks Their Cytotoxic Capacity J. Immunol., December 15, 2000; 165(12): 6776 - 6782. [Abstract] [Full Text] [PDF]

				U. Ziegner, D. Campbell, K. Weinhold, I. Frank, R. Rutstein, and S. E. Starr Deficient Antibody-Dependent Cellular Cytotoxicity against Human Immunodeficiency Virus (HIV)-Expressing Target Cells in Perinatal HIV Infection Clin. Vaccine Immunol., September 1, 1999; 6(5): 718 - 724. [Abstract] [Full Text] [PDF]